CONTINUUM Lifelong Learning in Neurology· 2026Q2
Diagnostic Approach to Neuropathy
- 1citations
- Q2SCImago
- 2026year
Short summary
Nearly half of polyneuropathy cases are still idiopathic, but recent research shows many are hereditary or acquired, necessitating advanced diagnostic techniques for effective management.
AI-generated from the title and abstract; the full text is not read.
Key points
- Approximately 50% of polyneuropathy cases are still classified as idiopathic.
- Diabetes is the leading risk factor for peripheral neuropathy, affecting one-third of patients.
- Many previously idiopathic cases are now understood to be hereditary or acquired.
- Advanced diagnostic techniques are essential for accurate diagnosis and effective management.
AI-generated from the title and abstract; the full text is not read.
Abstract
OBJECTIVE: This article provides an updated overview of polyneuropathy, emphasizing the significance of accurate diagnosis and the evolving understanding of its underlying causes and pathophysiology. LATEST DEVELOPMENTS: Recent research has revealed that many cases previously classified as idiopathic polyneuropathy are hereditary or acquired in origin. Advances in our understanding of complex pathophysiologic mechanisms have opened new therapeutic avenues, underscoring the need for a comprehensive diagnostic approach. ESSENTIAL POINTS: Nearly one-half of polyneuropathy cases remain idiopathic. Diabetes is the most common risk factor for peripheral neuropathy, present in one-third of patients. Improved diagnostic precision and insights into hereditary and acquired causes are crucial for effective management and treatment strategies. Care for these patients should integrate advanced techniques in the diagnosis of neuropathies.
The authors' abstract, as published at the source. CONTINUUM Lifelong Learning in Neurology, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Neurology (Medicine)
NeurologyMedicine